Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 after a Single-Dose Intravenous Administration - AZD6765

Exclusion Criteria

• - History of any clinically significant medical, neurologic or psychiatric disease as judged by the investigator
• - History of symptomatic orthostatic hypotension (ie, postural syncope)
• - Subjects who have received any radiolabelled study drug within 12 months of the Screening Visit.
• - Subjects who are monitored for radioactivity as part of their occupation
• - Subjects who have been exposed to radiation levels above background, (eg, throughX-Ray examinations) of >5mSv in the last year, >10 mSv over the last 5 years or a cumulative total of >1mSv per year of life.